Cite
Time to Reconsider VAD Therapy? A Review of Mortality and Quality of Life in Advanced Heart Failure Clinical Trials.
MLA
Heflin, Linden A., et al. “Time to Reconsider VAD Therapy? A Review of Mortality and Quality of Life in Advanced Heart Failure Clinical Trials.” Journal of Cardiac Failure, vol. 16, no. 8, Aug. 2010, p. S49. EBSCOhost, https://doi.org/10.1016/j.cardfail.2010.06.169.
APA
Heflin, L. A., Snyder, T. A., Nelson, K. E., Long, J. W., & Horstmanshof, D. A. (2010). Time to Reconsider VAD Therapy? A Review of Mortality and Quality of Life in Advanced Heart Failure Clinical Trials. Journal of Cardiac Failure, 16(8), S49. https://doi.org/10.1016/j.cardfail.2010.06.169
Chicago
Heflin, Linden A., Trevor A. Snyder, Karl E. Nelson, James W. Long, and Douglas A. Horstmanshof. 2010. “Time to Reconsider VAD Therapy? A Review of Mortality and Quality of Life in Advanced Heart Failure Clinical Trials.” Journal of Cardiac Failure 16 (8): S49. doi:10.1016/j.cardfail.2010.06.169.